BECN1 and intrahepatic cholangiocarcinoma: Consistent to 36.7% (66/180) patients staged to N1 in the present study, previous study reported that Beclin 1 was reduced expressed in primary ICC and the matched metastatic lymph nodes (29.6%, 32/108) [26].